Equities

Beijing Wandong Medical Technology Co Ltd

600055:SHH

Beijing Wandong Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)17.69
  • Today's Change0.600 / 3.51%
  • Shares traded20.49m
  • 1 Year change-0.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beijing Wandong Medical Technology Co., Ltd., formerly China Resources Wandong Medical Equipment Co., Ltd., is principally engaged in the development, manufacture and distribution of medical equipment. The Company's products consist of radiological imaging equipment, including angiographic and cardiac systems, digital direct radiography (DR) imaging equipment, high frequency diagnostic systems, high frequency radiographic systems, conventional x-ray diagnostic equipment and high frequency mobile units, magnetic resonance imaging (MRI) equipment, as well as digital medical image management systems, among others. The Company also provides maintenance services.

  • Revenue in CNY (TTM)1.40bn
  • Net income in CNY184.09m
  • Incorporated1997
  • Employees1.06k
  • Location
    Beijing Wandong Medical Technology Co LtdNo. 3 BuildingNo. 9 Courtyard, Jiuxianqiao East RoadChaoyang DistrictBEIJING 100015ChinaCHN
  • Phone+86 1 084569688
  • Fax+86 1 084575717
  • Websitehttps://www.wandong.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Microport EP MedTech Co Ltd383.99m35.90m9.84bn577.00274.125.69--25.630.07630.07630.8163.680.20811.307.04665,493.301.95--2.05--57.86--9.35--13.82--0.0109--26.46--85.17------
Vcanbio Cell & Gene Engineering Corp Ltd1.59bn107.45m10.16bn2.21k92.232.81--6.380.23540.23543.457.730.29771.902.59721,260.301.901.132.681.6168.1067.766.383.841.487.890.02960.002.243.78-5.7812.43-7.11--
Shenzhen YHLO Biotech Co Ltd1.90bn288.64m10.58bn1.76k36.933.98--5.560.50260.50263.324.660.48421.074.581,081,307.005.8516.437.4624.1663.9853.2612.0820.011.289.130.247430.28-48.4223.02-64.9356.3228.88--
Shinva Medical Instrument Co Ltd10.12bn692.34m10.92bn8.21k12.741.46--1.081.411.4118.3112.340.67752.204.961,232,589.004.724.639.1410.7625.6224.226.966.120.8303--0.163715.917.87-0.534230.7895.70-5.9061.86
Qingdao Haier Biomedical Co Ltd2.24bn358.01m11.35bn2.64k31.662.64--5.071.131.137.0413.530.40185.126.38848,473.706.5611.498.2915.2247.8249.9816.3425.202.53--0.031626.53-20.3622.07-32.4128.9420.64--
Shandong Weigao Orthopaedic Devce Co Ltd1.28bn154.60m11.78bn2.21k76.313.01--9.170.38580.38583.209.780.25240.67144.03581,131.603.1410.973.9513.6962.4077.3312.4327.083.62--0.009617.90-30.551.17-79.36-19.11-4.31--
Beijing Wandong Medical Technolgy Co Ltd1.40bn184.09m12.02bn1.06k65.232.54--8.560.2620.2622.006.740.26472.764.011,325,746.003.505.303.916.2138.8345.2113.2216.469.48--0.017935.8210.305.327.514.22-16.665.39
Shanghai Runda Medical Technology Co Ltd8.43bn40.27m12.83bn3.32k318.332.99--1.520.06730.067313.617.170.58314.191.492,543,990.001.184.783.1312.8625.9427.132.036.361.013.040.560912.43-12.848.93-34.580.85143.881.03
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.27bn657.34m12.97bn908.0019.333.34--10.225.445.4410.5931.540.3711.336.511,396,816.0019.0017.6821.5519.4374.5176.6051.2142.255.49--0.006744.4632.4338.7237.9840.2850.18--
Sansure Biotech Inc1.41bn259.42m13.37bn2.01k51.311.82--9.500.44750.44752.4412.620.16670.8782.03701,473.702.5226.742.7930.9776.4367.4715.1242.017.45--0.058322.40-84.3927.12-81.22121.8964.08--
Micro-Tech Nanjing Co Ltd2.68bn550.49m14.03bn2.40k25.413.76--5.242.942.9414.3019.860.61181.656.801,114,222.0012.8710.7415.2612.8266.0463.0421.0419.373.99--0.018335.4321.7821.2046.9920.3239.33--
Data as of Nov 15 2024. Currency figures normalised to Beijing Wandong Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

4.34%Per cent of shares held by top holders
HolderShares% Held
Hwabao WP Fund Management Co., Ltd.as of 30 Sep 202313.00m2.41%
China Southern Asset Management Co., Ltd.as of 30 Jun 20241.99m0.37%
GF Fund Management Co., Ltd.as of 30 Jun 20241.90m0.35%
The Vanguard Group, Inc.as of 02 Oct 20241.68m0.31%
Guotai Asset Management Co., Ltd.as of 30 Jun 20241.23m0.23%
China Asset Management Co., Ltd.as of 30 Jun 20241.15m0.21%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 20241.13m0.21%
China Europe Fund Management Co., Ltd.as of 30 Jun 2024517.80k0.10%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024493.40k0.09%
E Fund Management Co., Ltd.as of 30 Sep 2024371.10k0.07%
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.